Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: A potential role for GLP-1 in modulation of the diabetic pro-inflammatory state?

Daousi, Christina ; Pinkney, Jonathan H. ; Cleator, Jacqueline ; Wilding, John P. ; Ranganath, L. R.

Regulatory Peptides, May 10, 2013, Vol.183, p.54(8) [Periódico revisado por pares]

Texto completo disponível